Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis?
Journal of Neurology, Neurosurgery & Psychiatry
Fecha de publicación: 14 November 2019
Autores: Benjamin Gille, Maxim De Schaepdryver, Lieselot Dedeene, Janne Goossens, Kristl G Claeys, Ludo Van Den Bosch, Jos Tournoy, Philip Van Damme, Koen Poesen.
Background: Inflammation is a key pathological hallmark in amyotrophic lateral sclerosis (ALS), which seems to be linked to the disease progression. It is not clear what the added diagnostic and prognostic value are of inflammatory markers in the cerebrospinal fluid (CSF) of patients with ALS.